D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.61% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Financials | 8.17% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
PUT
AutoZone
AZO
$48.3B
| $62.1M | 0.1% |
104,300
+21,800
| +26% | +$11.6M |
|
|
EQC
252
DELISTED
Equity Commonwealth
EQC
| $62.1M | 0.1% |
2,041,746
-52,425
| -3% | -$1.62M |
|
253
American Electric Power
AEP
$73.7B
| $62M | 0.1% |
882,400
-284,700
| -24% | -$20.3M |
|
254
PUT
Bristol-Myers Squibb
BMY
$127B
| $61.5M | 0.09% |
965,000
-111,000
| -10% | -$6.48M |
|
255
Texas Instruments
TXN
$255B
| $61.1M | 0.09% |
681,374
-133,115
| -16% | -$10.9M |
|
256
F5
FFIV
$22.1B
| $60.8M | 0.09% |
504,677
+268,004
| +113% | +$32.4M |
|
257
United Airlines
UAL
$38.4B
| $60.8M | 0.09% |
998,631
+105,361
| +12% | +$7.02M |
|
258
PUT
Nike
NKE
$61.9B
| $60.5M | 0.09% |
1,166,100
+292,900
| +34% | +$16.4M |
|
259
Advanced Micro Devices
AMD
$851B
| $60.4M | 0.09% |
4,734,237
+1,540,966
| +48% | +$20.1M |
|
260
PUT
Costco
COST
$415B
| $60.2M | 0.09% |
366,600
+80,000
| +28% | +$12.6M |
|
261
Chemours
CC
$2.59B
| $60.1M | 0.09% |
1,188,435
-411,882
| -26% | -$19.4M |
|
|
CELG
262
CALL
DELISTED
Celgene Corp
CELG
| $60.1M | 0.09% |
412,100
+330,800
| +407% | +$45.1M |
|
|
263
PUT
Advanced Micro Devices
AMD
$851B
| $60M | 0.09% |
4,704,700
+2,706,700
| +135% | +$35.3M |
|
264
PUT
McDonald's
MCD
$188B
| $59.7M | 0.09% |
381,000
+137,000
| +56% | +$21.5M |
|
265
Carnival Corporation Ltd
CCL
$36.1B
| $59.2M | 0.09% |
916,265
+203,797
| +29% | +$13.6M |
|
266
Trane Technologies
TT
$106B
| $59.2M | 0.09% |
663,391
-225,961
| -25% | -$20M |
|
|
XEC
267
DELISTED
CIMAREX ENERGY CO
XEC
| $59M | 0.09% |
518,934
-407,198
| -44% | -$40.6M |
|
|
SYNH
268
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $59M | 0.09% |
1,127,423
-337,896
| -23% | -$18.8M |
|
269
ConocoPhillips
COP
$147B
| $58.9M | 0.09% |
1,176,700
+701,727
| +148% | +$31.5M |
|
|
SGI
270
Somnigroup International
SGI
$15.1B
| $58.9M | 0.09% |
3,650,128
+1,279,336
| +54% | +$18.9M |
|
271
PUT
Ford
F
$57.3B
| $58.8M | 0.09% |
4,914,800
+640,400
| +15% | +$7.22M |
|
272
CALL
Cisco
CSCO
$450B
| $58.6M | 0.09% |
1,741,400
+3,700
| +0.2% | +$118K |
|
273
Newmont
NEM
$98.2B
| $58.5M | 0.09% |
1,560,465
-379,610
| -20% | -$13.8M |
|
|
ANDV
274
DELISTED
Andeavor
ANDV
| $58.4M | 0.09% |
566,070
-106,684
| -16% | -$10.5M |
|
|
AGN
275
PUT
DELISTED
Allergan plc
AGN
| $58.4M | 0.09% |
284,800
+115,000
| +68% | +$26.7M |
|
Similar funds
D.E. Shaw & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.